E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 5/9/2022 in the Prospect News High Yield Daily.

New Issue: Kepler/Biofarma sells €345 million seven-year floater at Euribor plus 575 bps at 96

By Paul A. Harris

Portland, Ore., May 9 – Kepler SpA priced a €345 million issue of Euribor plus 575 basis points seven-year senior secured floating-rate notes (B3/B-) at 96 on Friday, according to a market source.

The spread came on top of spread talk. The issue price came at the cheap end of the 96 to 97 price talk.

The deal underwent document changes, sources said.

BNP Paribas was the left lead bookrunner. Joint bookrunners were Mediobanca and Nomura.

Proceeds plus balance sheet cash will be used to repay the bridge loan put in place to fund the acquisition of Biofarma SpA by France-based private equity investor Ardian SAS from White Bridge Investments.

Biofarma is an Italian supplier of personal care products, including nutritional supplements.

Issuer:Kepler SpA
Amount:€345 million
Issue:Senior secured floating-rate notes
Tenor:Seven years
Left bookrunner:BNP Paribas
Joint bookrunners:Mediobanca and Nomura
Coupon:Euribor plus 575 bps
Price:96
Call protection:One year
Trade date:May 6
Ratings:Moody's: B3
S&P: B-
Spread talk:Euribor plus 575 bps
Price talk:96 to 97

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.